voltage-dependent T-type calcium channel subunit alpha-1H inhibitor (RaQualia)

N/A

Report date: 2025/01/26 17:27:10
NME

Base Information

Drug Namevoltage-dependent T-type calcium channel subunit alpha-1H inhibitor (RaQualia)
Drug Alias NameCACNA1H subunit channel inhibitor (RaQualia)voltage-gated calcium channel subunit alpha Cav3.2 (RaQualia)RQ-00311651
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockersVoltage-dependent T-type calcium channel subunit alpha-1H antagonists
TargetsVoltage-gated T-type calcium channelVoltage-dependent T-type calcium channel subunit alpha-1H
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRaqualia Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesRaqualia Pharma Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A